Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma
2000

Vaccination Efficacy in Myeloma Patients

Sample size: 52 publication Evidence: low

Author Information

Author(s): Robertson J D, Nagesh K, Jowitt S N, Dougal M, Anderson H, Mutton K, Zambon M, Scarffe J H

Primary Institution: Christie Hospital NHS Trust

Hypothesis

How effective is vaccination against influenza and certain bacteria in patients with multiple myeloma?

Conclusion

The study found that routine vaccination against influenza and pneumococcal disease may not be effective in patients with multiple myeloma.

Supporting Evidence

  • No patient had protective antibody titres to all three antigens prior to vaccination.
  • Only 19% of patients achieved protective antibody titres post vaccination.
  • 93% of patients had suboptimal antibody titres before vaccination.

Takeaway

This study looked at how well vaccines work for people with a type of cancer called multiple myeloma, and it found that the vaccines didn't work very well.

Methodology

Patients were vaccinated and their antibody levels were measured before and after vaccination.

Limitations

The study had a small sample size and focused only on specific vaccines.

Participant Demographics

Patients with multiple myeloma attending outpatient clinics.

Digital Object Identifier (DOI)

10.1054/bjoc.1999.1088

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication